Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Clearmind Medicine Inc (CMND)

Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,007
  • Shares Outstanding, K 1,500
  • Annual Sales, $ 0 K
  • Annual Income, $ -3,860 K
  • EBIT $ -8 M
  • EBITDA $ -8 M
  • 60-Month Beta 1.51
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.12
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -19.72
  • Most Recent Earnings $-3.32 on 03/12/26
  • Next Earnings Date 06/11/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5949 +12.29%
on 03/18/26
1.2700 -47.40%
on 03/04/26
-0.4920 (-42.41%)
since 02/24/26
3-Month
0.5949 +12.29%
on 03/18/26
2.7800 -75.97%
on 01/22/26
-1.6220 (-70.83%)
since 12/24/25
52-Week
0.5949 +12.29%
on 03/18/26
52.4000 -98.73%
on 09/19/25
-43.1320 (-98.47%)
since 03/24/25

Most Recent Stories

More News
Moonage Media Review: Clearmind's MEAI and GLP-1 - Are These the Next-Generation Treatment for Weight Loss?

HONG KONG , Feb. 19, 2026 /PRNewswire/ -- As the multi-billion-dollar obesity treatment market continues to search for new therapeutic approaches beyond GLP-1 –based treatments, Clearmind Medicine...

CMND : 0.6680 (-0.52%)
Clearmind Medicine Inc. Signs Non-Binding Term Sheet with Dr. Glitter Pty Ltd for Development of MEAI-Based Alcohol Substitute

Clearmind and Dr. Glitter Pty Ltd plan to collaborate on a novel alcohol substitute using ActivCrystal™ technology.Quiver AI SummaryClearmind Medicine Inc. has signed a non-binding term sheet with Dr....

CMND : 0.6680 (-0.52%)
Clearmind Medicine to Present at the LD Micro Main Event XVI Investor Conference on October 4th

Tel Aviv, Israel and Vancouver, British Columbia--(Newsfile Corp. - September 28, 2023) - Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND) (FSE: CWY) ("Clearmind" or the "company"), a biotech company...

CMND.CN : 1.6000 (-12.57%)
CMND : 0.6680 (-0.52%)
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise

/PRNewswire/ -- The demand for abuse deterrent formulation technology is projected to grow due to growing misuse of drugs among the people. Growing demand for...

NTRB : 3.75 (-2.34%)
NTRBW : 1.5650 (+20.38%)
LLY : 903.02 (-0.83%)
MNMD : 15.02 (+1.01%)
CYBN : 8.28 (+1.22%)
CMND : 0.6680 (-0.52%)
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise

EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:CMND),(NASDAQ:MNMD),(NYSE:CYBN),(NYSE:LLY) EQNX::TICKER_END

NTRB : 3.75 (-2.34%)
NTRBW : 1.5650 (+20.38%)
LLY : 903.02 (-0.83%)
MNMD : 15.02 (+1.01%)
CYBN : 8.28 (+1.22%)
CMND : 0.6680 (-0.52%)

Business Summary

Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Clearmind Medicine Inc. is based in VANCOUVER.

See More

Key Turning Points

3rd Resistance Point 0.7120
2nd Resistance Point 0.6900
1st Resistance Point 0.6790
Last Price 0.6680
1st Support Level 0.6460
2nd Support Level 0.6240
3rd Support Level 0.6130

See More

52-Week High 52.4000
Fibonacci 61.8% 32.6105
Fibonacci 50% 26.4974
Fibonacci 38.2% 20.3844
Last Price 0.6680
52-Week Low 0.5949

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.